Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease

Peptides

Volumn 55, Issue , 2014, Pages 151-157

  Al Kindi, Hamood ^a   Hafiane, Anouar ^a   You, Zhipeng ^a   Albanese, Isabella ^a   Pilote, Louise ^a   Genest, Jacques ^a   Schwertani, Adel ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Acute coronary syndrome; Coronary artery disease; CRP; Ejection fraction; Plasma; Triglycerides; Troponin; UII; Urotensin II; Urotensin II related peptide; URP; UT

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UROTENSIN II; BIOLOGICAL MARKER; UROTENSIN;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UPREGULATION; AGED; BLOOD; CASE CONTROL STUDY;

ACUTE CORONARY SYNDROME; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; TRIGLYCERIDES; UROTENSINS;

EID: 84897391583     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.03.004     Document Type: Article

References (60)

1. J. Affolter, and D.J. Webb Urotensin II: a new mediator in cardiopulmonary regulation? Lancet 358 2001 774 775 (Pubitemid 32868720)
2. R.S. Ames, H.M. Sarau, J.K. Chambers, R.N. Willette, N.V. Aiyar, and A.M. Romanic et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 Nature 401 1999 282 286
3. T.J. Anderson, J. Gregoire, R.A. Hegele, P. Couture, G.B. Mancini, and R. McPherson et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult Can J Cardiol 29 2013 151 167
4. M. Babinska, M. Holecki, F. Prochaczek, A. Owczarek, D. Kokocinska, and J. Chudek et al. Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome? Arch Med Sci: AMS 8 2012 449 454
5. P.O. Barrette, and A.G. Schwertani A closer look at the role of urotensin II in the metabolic syndrome Front Endocrinol 3 2012 165
6. H.A. Bern, D. Pearson, B.A. Larson, and R.S. Nishioka Neurohormones from fish tails: the caudal neurosecretory system. I. Urophysiology and the caudal neurosecretory system of fishes Recent Prog Horm Res 41 1985 533 552
7. F. Bohm, and J. Pernow Urotensin II evokes potent vasoconstriction in humans in vivo Br J Pharmacol 135 2002 25 27 (Pubitemid 34102094)
8. N. Bousette, F. Hu, E.H. Ohlstein, D. Dhanak, S.A. Douglas, and A. Giaid Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation J Mol Cell Cardiol 41 2006 285 295 (Pubitemid 44080219)
9. N. Bousette, L. Patel, S.A. Douglas, E.H. Ohlstein, and A. Giaid Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta Atherosclerosis 176 2004 117 123 (Pubitemid 39078653)
10. Y.H. Chen, T.G. Yandle, A.M. Richards, and S.C. Palmer Urotensin II immunoreactivity in the human circulation: evidence for widespread tissue release Clin Chem 55 2009 2040 2048
11. M.B. Clearfield C-reactive protein: a new risk assessment tool for cardiovascular disease J Am Osteopath Assoc 105 2005 409 416 (Pubitemid 41603444)
12. Y. Coulouarn, I. Lihrmann, S. Jegou, Y. Anouar, H. Tostivint, and J.C. Beauvillain et al. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord Proc Natl Acad Sci U S A 95 1998 15803 15808 (Pubitemid 29018781)
13. H.Y. Dai, X.G. Guo, Z.M. Ge, Z.H. Li, X.J. Yu, and M.X. Tang et al. Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy J Diabet Complications 22 2008 137 143
14. S.A. Douglas, A.C. Sulpizio, V. Piercy, H.M. Sarau, R.S. Ames, and N.V. Aiyar et al. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey Br J Pharmacol 131 2000 1262 1274
15. S.A. Douglas, L. Tayara, E.H. Ohlstein, N. Halawa, and A. Giaid Congestive heart failure and expression of myocardial urotensin II Lancet 359 2002 1990 1997 (Pubitemid 34663713)
16. T. Dschietzig, C. Bartsch, R. Pregla, H.R. Zurbrugg, F.P. Armbruster, and C. Richter et al. Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure Regul Pept 110 2002 33 38 (Pubitemid 35435330)
17. N.A. Elshourbagy, S.A. Douglas, U. Shabon, S. Harrison, G. Duddy, and J.L. Sechler et al. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey Br J Pharmacol 136 2002 9 22 (Pubitemid 34499311)
18. S. Gao, Y.B. Oh, B.M. Park, W.H. Park, and S.H. Kim Urotensin II protects ischemic reperfusion injury of hearts through ROS and antioxidant pathway Peptides 36 2012 199 205
19. A. Gibson Complex effects of Gillichthys urotensin II on rat aortic strips Br J Pharmacol 91 1987 205 212 (Pubitemid 17083477)
20. D. Gruson, M.F. Rousseau, S.A. Ahn, F. van Linden, and J.M. Ketelslegers Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers Peptides 27 2006 1527 1531
21. D. Gruson, M.F. Rousseau, J.M. Ketelslegers, and M.P. Hermans Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotype J Clin Hypertens (Greenwich, Conn) 12 2010 653 660
22. G.S. Hassan, S.A. Douglas, E.H. Ohlstein, and A. Giaid Expression of urotensin-II in human coronary atherosclerosis Peptides 26 2005 2464 2472 (Pubitemid 41676718)
23. M. Heringlake, T. Kox, O. Uzun, B. Will, L. Bahlmann, and S. Klaus et al. The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease Regul Pept 121 2004 129 136 (Pubitemid 38901071)
24. H. Itoh, D. McMaster, and K. Lederis Functional receptors for fish neuropeptide urotensin II in major rat arteries Eur J Pharmacol 149 1988 61 66
25. D. Joyal, T. Huynh, N. Aiyar, B. Guida, S. Douglas, and A. Giaid Urotensin-II levels in acute coronary syndromes Int J Cardiol 108 2006 31 35 (Pubitemid 43324903)
26. S.Q. Khan, S.S. Bhandari, P. Quinn, J.E. Davies, and L.L. Ng Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans Int J Cardiol 117 2007 323 328 (Pubitemid 46507623)
27. H. Lapp, G. Boerrigter, L.C. Costello-Boerrigter, K. Jaekel, T. Scheffold, and I. Krakau et al. Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy Int J Cardiol 94 2004 93 97 (Pubitemid 38314694)
28. L. Leifeld, C. Clemens, J. Heller, J. Trebicka, T. Sauerbruch, and U. Spengler Expression of urotensin II and its receptor in human liver cirrhosis and fulminant hepatic failure Dig Dis Sci 55 2010 1458 1464
29. D. Liu, J. Chen, J. Wang, Z. Zhang, X. Ma, and J. Jia et al. Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension Int J Mol Med 25 2010 845 851
30. J.J. Maguire, R.E. Kuc, and A.P. Davenport Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 Br J Pharmacol 131 2000 441 446
31. R.J. O'Brien, I. Loke, J.E. Davies, I.B. Squire, and L.L. Ng Myotrophin in human heart failure J Am Coll Cardiol 42 2003 719 725 (Pubitemid 37000193)
32. S. Okumus, Y.Z. Igci, T. Taskin, S. Oztuzcu, B. Gurler, and Z. Eslik et al. Association between Thr21Met and Ser89Asn polymorphisms of the urotensin-II (UTS2) gene, diabetes mellitus, and diabetic retinopathy Curr Eye Res 37 2012 921 929
33. K.L. Ong, L.Y. Wong, and B.M. Cheung The role of urotensin II in the metabolic syndrome Peptides 29 2008 859 867 (Pubitemid 351540831)
34. O. Ozer, V. Davutoglu, S. Ercan, M. Akcay, I. Sari, and M. Sucu et al. Plasma urotensin II as a marker for severity of rheumatic valve disease Tohoku J Exp Med 218 2009 57 62
35. R. Pakala Role of urotensin II in atherosclerotic cardiovascular diseases Cardiovasc Revasc Med 9 2008 166 178 (Pubitemid 351905943)
36. R. Pawar, W. Kemp, S. Roberts, H. Krum, T. Yandle, and W. Hardikar Urotensin II levels are an important marker for the severity of portal hypertension in children J Pediatr Gastroenterol Nutr 53 2011 88 92
37. J. Paysant, A. Rupin, S. Simonet, J.N. Fabiani, and T.J. Verbeuren Comparison of the contractile responses of human coronary bypass grafts and monkey arteries to human urotensin-II Fundam Clin Pharmacol 15 2001 227 231 (Pubitemid 32939490)
38. D. Pearson, J.E. Shively, B.R. Clark, I.I. Geschwind, M. Barkley, and R.S. Nishioka et al. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes Proc Natl Acad Sci U S A 77 1980 5021 5024 (Pubitemid 11236553)
39. M.B. Pepys, and G.M. Hirschfield C-reactive protein: a critical update J Clin Invest 111 2003 1805 1812 (Pubitemid 38057722)
40. H.C. Prosser, M.E. Forster, A.M. Richards, and C.J. Pemberton Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury Peptides 29 2008 770 777 (Pubitemid 351522361)
41. M.P. Quaile, H. Kubo, C.L. Kimbrough, S.A. Douglas, and K.B. Margulies Direct inotropic effects of exogenous and endogenous urotensin-II: divergent actions in failing and nonfailing human myocardium Circ Heart Fail 2 2009 39 46
42. M.T. Rademaker, C.J. Charles, E.A. Espiner, S. Fisher, C.M. Frampton, and C.M. Kirkpatrick et al. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep J Am Coll Cardiol 40 2002 1495 1505 (Pubitemid 35192877)
43. E. Rakowski, G.S. Hassan, D. Dhanak, E.H. Ohlstein, S.A. Douglas, and A. Giaid A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker J Mol Cell Cardiol 39 2005 785 791 (Pubitemid 41464415)
44. F.D. Russell Urotensin II in cardiovascular regulation Vasc Health Risk Manag 4 2008 775 785
45. F.D. Russell, D. Meyers, A.J. Galbraith, N. Bett, I. Toth, and P. Kearns et al. Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure Am J Physiol Heart Circ Physiol 285 2003 H1576 H1581
46. F.D. Russell, and P. Molenaar Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart Cardiovasc Res 63 2004 673 681 (Pubitemid 39078681)
47. F.D. Russell, P. Molenaar, and D.M. O'Brien Cardiostimulant effects of urotensin-II in human heart in vitro Br J Pharmacol 132 2001 5 9 (Pubitemid 32128427)
48. M.E. Saez, T. Smani, R. Ramirez-Lorca, I. Diaz, M. Serrano-Rios, and A. Ruiz et al. Association analysis of urotensin II gene (UTS2) and flanking regions with biochemical parameters related to insulin resistance PLOS ONE 6 2011 e19327
49. C.M. Simpson, D.J. Penny, C.F. Stocker, and L.S. Shekerdemian Urotensin II is raised in children with congenital heart disease Heart (Br Card Soc) 92 2006 983 984 (Pubitemid 43974071)
50. A. Stirrat, M. Gallagher, S.A. Douglas, E.H. Ohlstein, C. Berry, and A. Kirk et al. Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries Am J Physiol Heart Circ Physiol 280 2001 H925 H928
51. T. Suguro, T. Watanabe, Y. Ban, S. Kodate, A. Misaki, and T. Hirano et al. Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension Am J Hypertens 20 2007 211 217 (Pubitemid 46150023)
52. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, and H.D. White et al. Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
53. A. Tzanidis, R.D. Hannan, W.G. Thomas, D. Onan, D.J. Autelitano, and F. See et al. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy Circ Res 93 2003 246 253 (Pubitemid 36993236)
54. T. Watanabe, R. Pakala, T. Katagiri, and C.R. Benedict Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells Circulation 104 2001 16 18 (Pubitemid 32623283)
55. T. Watanabe, R. Pakala, T. Katagiri, and C.R. Benedict Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation J Hypertens 19 2001 2191 2196 (Pubitemid 33135241)
56. T. Watanabe, T. Suguro, T. Kanome, Y. Sakamoto, S. Kodate, and T. Hagiwara et al. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages Hypertension 46 2005 738 744 (Pubitemid 43186747)
57. Z. You, J. Genest Jr., P.O. Barrette, A. Hafiane, D.J. Behm, and P. D'Orleans-Juste et al. Genetic and pharmacological manipulation of urotensin II ameliorate the metabolic and atherosclerosis sequalae in mice Arterioscler Thromb Vasc Biol 32 2012 1809 1816
58. J.Y. Zhang, Z.W. Chen, and H. Yao Protective effect of urantide against ischemia-reperfusion injury via protein kinase C and phosphtidylinositol 3′-kinase - Akt pathway Can J Physiol Pharmacol 90 2012 637 645
59. L. Zhang, R. Ding, Y. Zhen, and Z.G. Wu Relation of urotensin II levels to lone atrial fibrillation Am J Cardiol 104 2009 1704 1707
60. C. Zoccali, and F. Mallamaci Urotensin II: a cardiovascular and renal update Curr Opin Nephrol Hypertens 17 2008 199 204 (Pubitemid 351253047)